News
Fangzhou has signed a MoU with Novo Nordisk to collaborate on the management of serious chronic diseases, including obesity and diabetes.
A WOMAN who’s shed nearly 25% of her bodyweight thanks to Mounjaro has revealed which foods she steered clear of. TikToker ...
4h
The Chosun Ilbo on MSNS. Korean companies join global race for obesity drugsAs the global obesity medication market skyrockets, South Korean pharmaceuticals are rushing to develop national obesity ...
With their lengthening laundry list of health benefits, drugs like Ozempic and Wegovy are showing promise outside of weight loss and diabetes treatments. One of the most exciting off-label uses of ...
Pre-diabetes now affects as many as one-third of children ages 12-17. As a physician this is why Ozempic should still not be ...
Novo Nordisk A/S (NYSE: NVO) is one of the high-margin pharma stocks to buy now. Berenberg has reaffirmed its Hold rating on ...
Explore more
It turns out that obesity may be much more complicated than we thought, with the condition potentially existing in up to 11 ...
From legal pitfalls to temperature-sensitive drugs, here’s how to travel safely and legally with your medication ...
2d
Zacks Investment Research on MSNCan Wegovy & Ozempic Drive Another Strong Quarter for Novo Nordisk?Novo Nordisk NVO generates most of its revenues from the sales of its blockbuster GLP-1 injections, Ozempic for type II ...
On April 29, 2025, Hims & Hers and Novo Nordisk unveiled a landmark collaboration to bring Wegovy—Novo's blockbuster ...
You can bring needles and injectable medicines like EpiPens (for allergies), insulin or Wegovy in your hand luggage. But it’s important to carry a doctor’s note stating your medical condition and the ...
In Novo Nordisk A/S’s home country of Denmark, the popularity of weight-loss drugs is fueling economic growth, but local ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results